Sponsored by:
Chairs: Ian Davis and Dickon Hayne
Renal Cell Carcinoma – An Update for 2013 (#32)
12:45 PM
DILIGENCE-1: Dovitinib In 1st-Line Renal Cell Carcinoma, an Investigation into tumour GENe status and Correlation with Efficacy – 1st exploratory study (#33)
12:45 PM
Bladder preservation strategies in the treatment of invasive urothelial cancer (#34)
12:45 PM
Patients from regional areas undergoing cystectomy for bladder cancer exhibit more advanced pathological features and have poorer overall survival than their metropolitan counterparts (#35)
12:45 PM